Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 42 | 2024 | 6965 | 2.110 |
Why?
|
Occult Blood | 16 | 2024 | 199 | 2.040 |
Why?
|
Early Detection of Cancer | 27 | 2024 | 3235 | 1.620 |
Why?
|
Colonoscopy | 18 | 2024 | 1409 | 1.590 |
Why?
|
Colonography, Computed Tomographic | 9 | 2021 | 170 | 0.900 |
Why?
|
Mass Screening | 25 | 2024 | 5454 | 0.870 |
Why?
|
Cost-Benefit Analysis | 20 | 2024 | 5536 | 0.530 |
Why?
|
Adenoma | 10 | 2024 | 2155 | 0.500 |
Why?
|
Feces | 9 | 2024 | 1505 | 0.450 |
Why?
|
Advisory Committees | 1 | 2016 | 797 | 0.390 |
Why?
|
Models, Theoretical | 5 | 2020 | 3563 | 0.380 |
Why?
|
Preventive Health Services | 1 | 2016 | 570 | 0.370 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2023 | 2039 | 0.370 |
Why?
|
Models, Statistical | 7 | 2021 | 5092 | 0.370 |
Why?
|
Direct Service Costs | 1 | 2010 | 61 | 0.350 |
Why?
|
Sigmoidoscopy | 4 | 2021 | 150 | 0.350 |
Why?
|
Quality-Adjusted Life Years | 5 | 2024 | 1740 | 0.300 |
Why?
|
Sensitivity and Specificity | 14 | 2024 | 14653 | 0.290 |
Why?
|
Models, Economic | 3 | 2024 | 719 | 0.270 |
Why?
|
Computer Simulation | 12 | 2024 | 6258 | 0.230 |
Why?
|
Betamethasone | 1 | 2024 | 48 | 0.230 |
Why?
|
Life Expectancy | 5 | 2021 | 1248 | 0.230 |
Why?
|
Gallbladder Neoplasms | 1 | 2023 | 190 | 0.190 |
Why?
|
Polyps | 1 | 2023 | 200 | 0.190 |
Why?
|
Health Status Disparities | 3 | 2020 | 1880 | 0.190 |
Why?
|
DNA, Neoplasm | 2 | 2019 | 1741 | 0.170 |
Why?
|
Ovarian Cysts | 1 | 2020 | 107 | 0.170 |
Why?
|
Breast Neoplasms | 3 | 2023 | 21162 | 0.170 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13489 | 0.160 |
Why?
|
Time | 1 | 2020 | 550 | 0.160 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2019 | 86 | 0.150 |
Why?
|
Pancreatic Neoplasms | 3 | 2023 | 5444 | 0.150 |
Why?
|
Ovarian Neoplasms | 3 | 2020 | 4903 | 0.150 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2019 | 1757 | 0.140 |
Why?
|
Kidney Diseases, Cystic | 1 | 2018 | 182 | 0.130 |
Why?
|
Health Care Costs | 5 | 2019 | 3240 | 0.130 |
Why?
|
Drug Therapy | 1 | 2019 | 504 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2024 | 2353 | 0.130 |
Why?
|
Medically Underserved Area | 1 | 2018 | 268 | 0.130 |
Why?
|
Aged, 80 and over | 14 | 2023 | 59548 | 0.130 |
Why?
|
Gestational Age | 1 | 2024 | 3617 | 0.120 |
Why?
|
Humans | 59 | 2024 | 766812 | 0.120 |
Why?
|
Aged | 26 | 2024 | 171344 | 0.120 |
Why?
|
Middle Aged | 30 | 2024 | 223267 | 0.110 |
Why?
|
Calibration | 2 | 2024 | 814 | 0.110 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2018 | 488 | 0.110 |
Why?
|
Immunoassay | 2 | 2014 | 744 | 0.110 |
Why?
|
Patient Compliance | 3 | 2014 | 2694 | 0.110 |
Why?
|
United States | 17 | 2024 | 72945 | 0.110 |
Why?
|
Incidental Findings | 1 | 2018 | 698 | 0.100 |
Why?
|
Sex Factors | 5 | 2021 | 10619 | 0.100 |
Why?
|
Hematologic Tests | 2 | 2024 | 239 | 0.100 |
Why?
|
Premature Birth | 1 | 2024 | 1830 | 0.100 |
Why?
|
Immunologic Tests | 1 | 2012 | 101 | 0.100 |
Why?
|
Age Factors | 8 | 2018 | 18397 | 0.090 |
Why?
|
Decision Support Techniques | 4 | 2018 | 2007 | 0.090 |
Why?
|
Medicare | 5 | 2023 | 6813 | 0.090 |
Why?
|
Female | 30 | 2024 | 396532 | 0.090 |
Why?
|
Minority Groups | 1 | 2018 | 1208 | 0.090 |
Why?
|
Risk | 2 | 2021 | 9602 | 0.090 |
Why?
|
Cost Savings | 1 | 2015 | 903 | 0.080 |
Why?
|
Practice Guidelines as Topic | 2 | 2018 | 7430 | 0.080 |
Why?
|
Informed Consent | 1 | 2016 | 1010 | 0.080 |
Why?
|
Medically Uninsured | 1 | 2014 | 838 | 0.080 |
Why?
|
Duodenal Neoplasms | 1 | 2009 | 114 | 0.080 |
Why?
|
Poverty | 2 | 2018 | 2714 | 0.080 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 2188 | 0.070 |
Why?
|
Time Factors | 5 | 2020 | 40149 | 0.070 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2009 | 219 | 0.070 |
Why?
|
Cohort Studies | 4 | 2021 | 41706 | 0.070 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2011 | 542 | 0.070 |
Why?
|
Adult | 12 | 2024 | 223305 | 0.070 |
Why?
|
Analgesics, Opioid | 2 | 2023 | 3837 | 0.070 |
Why?
|
DNA | 2 | 2021 | 7210 | 0.070 |
Why?
|
Male | 25 | 2024 | 364154 | 0.070 |
Why?
|
Pancreaticoduodenectomy | 1 | 2009 | 515 | 0.060 |
Why?
|
Hypercholesterolemia | 2 | 1999 | 1145 | 0.060 |
Why?
|
SEER Program | 3 | 2018 | 1444 | 0.060 |
Why?
|
Hemoglobins | 1 | 2011 | 1531 | 0.060 |
Why?
|
Lung | 1 | 2023 | 10068 | 0.060 |
Why?
|
Comorbidity | 4 | 2023 | 10580 | 0.060 |
Why?
|
Substance-Related Disorders | 1 | 2020 | 4421 | 0.050 |
Why?
|
Monte Carlo Method | 2 | 2024 | 1251 | 0.050 |
Why?
|
Algorithms | 1 | 2024 | 14073 | 0.050 |
Why?
|
Population Surveillance | 2 | 2011 | 2594 | 0.050 |
Why?
|
Risk Assessment | 3 | 2020 | 24299 | 0.050 |
Why?
|
Quality Improvement | 1 | 2018 | 3850 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2018 | 3186 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11062 | 0.050 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2024 | 239 | 0.050 |
Why?
|
Neoplasms | 2 | 2009 | 22350 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2018 | 4282 | 0.050 |
Why?
|
Markov Chains | 2 | 2018 | 974 | 0.040 |
Why?
|
Naloxone | 1 | 2023 | 372 | 0.040 |
Why?
|
Fibrin | 1 | 2002 | 514 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3692 | 0.040 |
Why?
|
Health Policy | 1 | 2011 | 2697 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11876 | 0.040 |
Why?
|
American Cancer Society | 1 | 2018 | 69 | 0.040 |
Why?
|
Incidence | 4 | 2020 | 21527 | 0.040 |
Why?
|
Weight Loss | 1 | 1999 | 2712 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20710 | 0.040 |
Why?
|
Delivery, Obstetric | 1 | 2024 | 949 | 0.040 |
Why?
|
Obesity | 2 | 1999 | 13090 | 0.030 |
Why?
|
Cesarean Section | 1 | 2024 | 1418 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2024 | 2158 | 0.030 |
Why?
|
Infant, Premature | 1 | 2024 | 2120 | 0.030 |
Why?
|
Health Services Research | 2 | 2015 | 1811 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15425 | 0.030 |
Why?
|
South Carolina | 1 | 2014 | 113 | 0.030 |
Why?
|
Young Adult | 1 | 2021 | 59939 | 0.030 |
Why?
|
Furans | 1 | 2014 | 199 | 0.030 |
Why?
|
Kallikreins | 1 | 2014 | 219 | 0.030 |
Why?
|
Hypertension | 2 | 1999 | 8616 | 0.030 |
Why?
|
Disease Progression | 3 | 2018 | 13642 | 0.020 |
Why?
|
Body Mass Index | 1 | 1999 | 13050 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2014 | 11094 | 0.020 |
Why?
|
Survival Rate | 2 | 2018 | 12826 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11218 | 0.020 |
Why?
|
Phenols | 1 | 2014 | 526 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9464 | 0.020 |
Why?
|
Ultrasonography | 1 | 2023 | 5990 | 0.020 |
Why?
|
Public Health | 1 | 2023 | 2680 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2007 | 10384 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2012 | 958 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3552 | 0.020 |
Why?
|
Capsule Endoscopy | 1 | 2010 | 107 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6853 | 0.020 |
Why?
|
Models, Econometric | 1 | 1999 | 215 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6514 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2014 | 1667 | 0.020 |
Why?
|
Research | 1 | 2016 | 1977 | 0.020 |
Why?
|
Risk Factors | 3 | 2023 | 74889 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8540 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3717 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8728 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3530 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2902 | 0.020 |
Why?
|
Organizational Policy | 1 | 2008 | 434 | 0.020 |
Why?
|
Coronary Disease | 2 | 1999 | 5915 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 2010 | 670 | 0.010 |
Why?
|
Rectal Neoplasms | 1 | 2013 | 1183 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2014 | 2463 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2024 | 26387 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 1999 | 15652 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2008 | 1186 | 0.010 |
Why?
|
Mammography | 1 | 2014 | 2429 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8734 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1999 | 1478 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 30236 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2011 | 1958 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2002 | 6575 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3411 | 0.010 |
Why?
|
Mortality | 1 | 2013 | 2908 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2009 | 1394 | 0.010 |
Why?
|
Infant | 2 | 2023 | 36459 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15835 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2535 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9661 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9407 | 0.010 |
Why?
|
Health Surveys | 1 | 2011 | 4055 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2011 | 2171 | 0.010 |
Why?
|
Solubility | 1 | 2002 | 1078 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5513 | 0.010 |
Why?
|
Cost of Illness | 1 | 1999 | 1949 | 0.010 |
Why?
|
Thrombophilia | 1 | 2002 | 308 | 0.010 |
Why?
|
Societies, Medical | 1 | 2011 | 3957 | 0.010 |
Why?
|
Carcinoma | 1 | 2010 | 2325 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2694 | 0.010 |
Why?
|
Reference Standards | 1 | 2002 | 1010 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10101 | 0.010 |
Why?
|
Contrast Media | 1 | 2011 | 5329 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2018 | 65286 | 0.010 |
Why?
|
Troponin T | 1 | 2002 | 786 | 0.010 |
Why?
|
Decision Making | 1 | 2011 | 3951 | 0.010 |
Why?
|
Dengue | 1 | 1980 | 258 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20146 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39312 | 0.010 |
Why?
|
Prognosis | 2 | 2009 | 29959 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 1999 | 12246 | 0.010 |
Why?
|
Chest Pain | 1 | 2002 | 1101 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 3803 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2008 | 4306 | 0.010 |
Why?
|
Disease Outbreaks | 1 | 1980 | 1761 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 81657 | 0.010 |
Why?
|
Quality of Life | 1 | 2009 | 13476 | 0.000 |
Why?
|
Stroke | 1 | 1999 | 9744 | 0.000 |
Why?
|
Hemagglutination Inhibition Tests | 1 | 1980 | 87 | 0.000 |
Why?
|
Malaysia | 1 | 1980 | 107 | 0.000 |
Why?
|
Culicidae | 1 | 1980 | 111 | 0.000 |
Why?
|
Insect Vectors | 1 | 1980 | 136 | 0.000 |
Why?
|
Dengue Virus | 1 | 1980 | 204 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1980 | 3213 | 0.000 |
Why?
|
Child, Preschool | 1 | 1980 | 42577 | 0.000 |
Why?
|
Child | 1 | 1980 | 80670 | 0.000 |
Why?
|
Adolescent | 1 | 1980 | 88902 | 0.000 |
Why?
|
Concepts
(196)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_